Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

All-on-Four Implants With Ultrasonic (Nobelsinus)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03357692
Recruitment Status : Withdrawn (no enough patients have been enrolled)
First Posted : November 30, 2017
Last Update Posted : September 17, 2020
Sponsor:
Information provided by (Responsible Party):
Mr. Claudio Stacchi, DDS, MSc, International Piezosurgery Academy

Brief Summary:
The objective of this observational study is the radiographic evaluation of marginal bone remodeling after surgical implant insertion in an immediate loading all-on-four technique with trans-sinusal titanium implants, correlating the gingival thickness and the height of the implant prosthetic stump with the proportion of the abovementioned marginal bone remodeling.

Condition or disease Intervention/treatment Phase
Bone Atrophy, Alveolar Procedure: all on four implant rehabilitation Not Applicable

Detailed Description:

The extent of marginal bone remodeling around the neck of dental implants has been used for many years as a criterion for defining its long-term success.

In fact, the etiology of this Marginal Bone Loss has not yet been well understood, although many theories have been proposed to explain it.

The influence of the thickness of the mucous membrane on marginal bone loss was discussed elsewhere which suggests a protective action for the underlying soft tissue that recreates a kind of "biological amplitude" around the implant. Some studies have suggested that a marginally oscillating bone loss between 1.5 and 2.0 mm provides the vertical space for proper restoration of the biological amplitude. Some authors. published a study that demonstrated that, in crestal systems with switching platforms, a vertical thickness of soft tissue greater than 2 mm is effective in preventing periimplant crestal bone loss. However, the severity of the sample examined precludes the possibility of making definitive conclusions.

Recently other authors have shown significant marginal bone loss around implants with lower prosthetic implants than those with higher prosthetic prostheses, without however measuring the thickness of soft tissues and evaluating their influence. In particular, the extent of bone loss was extremely limited when the height of the stump was equal to or greater than 2 mm. From a theoretical point of view, a prosthetic abutment of at least 2 mm high, calculated from the apical margin of the crown to the platform of the implant, should provide adequate space for restoring the biological amplitude.

It can therefore be hypothesized that these two factors (the vertical thickness of soft tissues and the height of the prosthetic stump) are the expression of the same principle: the restoration of the biological amplitude around the implant's neck. From a clinical point of view it will be useful to determine which of the two factors is most important in preventing and limiting periimplant bone loss.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Ultrasonic Preparation of the Implant Site in the All-on-Four Technique With Trans-sinus Implants
Actual Study Start Date : October 31, 2017
Actual Primary Completion Date : October 31, 2019
Actual Study Completion Date : February 15, 2020

Arm Intervention/treatment
Experimental: maxillary total edentulism
all on four implant rehabilitation with trans-sinusal implants
Procedure: all on four implant rehabilitation
implant insertion after piezoelectric site preparation for trans-sinusal implants




Primary Outcome Measures :
  1. survival rate [ Time Frame: two years after surgery ]
    percentage of implants surviving in oral cavity


Secondary Outcome Measures :
  1. radiographic distance between crestal bone and implant platform [ Time Frame: two years after surgery ]
    radiographically assessed



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   19 Months and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. indications for implant insertion into the maxillary upper jaw, based on a careful diagnosis and treatment plan;
  2. presence of a residual bone crest with a minimum surgical height of 4 mm at the maxillary sinus (bilaterally), and a thickness of at least 6 mm at the two distally programmed implant sites;
  3. presence of a residual bone crest with a minimum surgical height of 10 mm at the anterior maxilla, and a thickness of at least 6 mm at the mesially programmed implant sites;
  4. the bone crest should be healed (at least 6 months after the loss / extraction of the corresponding dental element);
  5. no regenerated bone;
  6. Plaque index below 25% and bleeding index less than 20%;
  7. the buccal length of the adherent gingiva ≥ 4 mm;
  8. age of the patient> 18 years;
  9. systemic condition of the compensated patient (American Society of Anesthesiologist score < 2);

8) Patients should be able to examine and understand the protocol of study; 9) subscribing to informed consent.

Exclusion Criteria:

  1. not treated diabetes
  2. cardiovascular disease
  3. incapability of maintaining a good oral hygiene

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03357692


Locations
Layout table for location information
Italy
Piezosurgery Academy
Parma, Italy, 43100
Sponsors and Collaborators
International Piezosurgery Academy
Investigators
Layout table for investigator information
Study Director: Claudio Stacchi, Dr International Piezosurgery Academy
Publications:
Layout table for additonal information
Responsible Party: Mr. Claudio Stacchi, DDS, MSc, President of the International Piezosurgery Academy, International Piezosurgery Academy
ClinicalTrials.gov Identifier: NCT03357692    
Other Study ID Numbers: Nobelsinus
First Posted: November 30, 2017    Key Record Dates
Last Update Posted: September 17, 2020
Last Verified: September 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Mr. Claudio Stacchi, DDS, MSc, International Piezosurgery Academy:
all on four; piezoelectric; implant; trans-sinusal
Additional relevant MeSH terms:
Layout table for MeSH terms
Alveolar Bone Loss
Atrophy
Pathological Conditions, Anatomical
Bone Resorption
Bone Diseases
Musculoskeletal Diseases
Periodontal Atrophy
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases